Atacand, Candesartan Newswire

Atacand, Candesartan Newswire

Comprehensive Real-Time News Feed for Atacand, Candesartan (generic).

Results 1 - 20 of 48 in Atacand, Candesartan (generic)

  1. Atacand Blood Pressure Medication: Benefits and Side Effects You Should KnowRead the original story w/Photo

    Yesterday | News Max

    Atacand is a medication that lowers blood pressure by preventing blood vessels from narrowing to encourage normal circulation in patients with high blood pressure. Lowering blood pressure helps to reduce the risk of heart complications, including heart attack, stroke, and heart failure.

    Comment?

  2. Subclinical growth of an arteriovenous fistula associated with renal biopsy: a case reportRead the original story w/Photo

    Monday Jul 11 | BioMed Central

    Renal biopsy is not free from complications and patients who undergo this procedure are usually hospitalized to receive intensive care for several days after biopsy. In contrast, after this period, routine follow-up to detect biopsy-associated complications is rarely scheduled, unless the patient develops a clinical manifestation.

    Comment?

  3. Candesartan doesn't prevent trastuzumab cardiotoxicityRead the original story w/Photo

    Jun 25, 2016 | PhysOrg Weblog

    In patients with early breast cancer, candesartan does not protect against trastuzumab-related cardiotoxic effects, according to a study published online June 23 in JAMA Oncology . Annelies H. Boekhout, Ph.D., from the Netherlands Cancer Institute in Amsterdam, and colleagues conducted a randomized placebo -controlled trial involving 210 women with early breast cancer testing positive for human epidermal growth factor receptor 2. Patients were randomized to 78 weeks of candesartan or placebo ; treatment started on the same day as the first trastuzumab treatment.

    Comment?

  4. Angiotensin II increases fibronectin and collagen I through the...Read the original story

    Jun 14, 2016 | CiteULike

    The contribution of angiotensin II to renal and tubular fibrosis has been widely reported. Recent studies have shown that collecting duct cells can undergo mesenchymal transition suggesting that collecting duct cells are involved in interstitial fibrosis.

    Comment?

  5. Monoclonal antibodies could become additional migraine therapy optionRead the original story w/Photo

    Jun 1, 2016 | PhysOrg Weblog

    Preventing or shortening the duration of migraine attacks - established drug treatment options and those that could shape future therapies were discussed at the Congress of European Academy of Neurology in Copenhagen. Affecting six to eight percent of males and ten to twelve percent of females, migraine is among the most prevalent neurological conditions.

    Comment?

  6. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular DiseaseRead the original story

    May 26, 2016 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. In a 2-by-2 factorial trial, 12,705 persons at intermediate risk were assigned to candesartan plus hydrochlorothiazide or placebo and to rosuvastatin or placebo.

    Comment?

  7. Cell membranesa and how long drugs may exert beneficial pharmacological activity in vivo.Read the original story

    May 9, 2016 | CiteULike

    The time course of the beneficial pharmacological effect of a drug has long been considered to depend merely on the temporal fluctuation of its free concentration. Only in the last decade has it become widely accepted that target-binding kinetics can also affect in vivo pharmacological activity.

    Comment?

  8. Anti-Hypertensive Therapeutics in Asia-Pacific Markets to 2021 -...Read the original story w/Photo

    May 6, 2016 | SBWire

    Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate of 1.2% to 561 million in 2021 in the four Asia-Pacific regions of China, India, Australia, and Japan.

    Comment?

  9. Global research sees statin benefits in lower risk patientsRead the original story w/Photo

    Apr 13, 2016 | Alaska Journal of Commerce

    The first major research of its kind shows that cholesterol-lowering statins can prevent heart attacks and strokes in a globally diverse group of older people who don't have heart disease. The aim was to prevent heart problems using a statin alone, blood pressure drugs or a combination of the two.

    Comment?

  10. Global research sees statin benefits in lower risk patientsRead the original story w/Photo

    Apr 9, 2016 | The Janesville Gazette

    The first major research of its kind shows that cholesterol-lowering statins can prevent heart attacks and strokes in a globally diverse group of older people who don't have heart disease. The aim was to prevent heart problems using a statin alone, blood pressure drugs or a combination of the two.

    Comment?

  11. Correction: Heart Drugs-Prevention storyRead the original story w/Photo

    Apr 7, 2016 | Kansas City Nursing News

    In a story April 2 about research testing cholesterol-lowering drugs to prevent heart problems, The Associated Press misspelled the last name of a Chicago cardiologist. The correct spelling is Dr. Clyde Yancy, not Yancey.

    Comment?

  12. Global study lays groundwork for daily statin usage to prevent heart diseaseRead the original story w/Photo

    Apr 5, 2016 | CNN

    The participants in the study spanned six continents and were in a variety of ethnic groups; 46% of the participants were women In an effort to reduce cardiovascular disease, which causes 18 million deaths globally per year and affects more than 1 billion adults worldwide, researchers are suggesting the daily usage of cholesterol lowering drugs, called statins, according to a study released in the New England Journal of Medicine. In a trial spanning six continents, 21 countries and 12,705 ethnically diverse participants, the researchers randomly assigned placebos and low dosages of statins or antihypertensives, such as rosuvastatin and candesartan plus hydrochlorothiazide.

    Comment?

  13. Global study lays groundwork for daily statin usageRead the original story w/Photo

    Apr 4, 2016 | WAPT-TV Jackson

    In an effort to reduce cardiovascular disease, which causes 18 million deaths globally per year and affects more than 1 billion adults worldwide, researchers are suggesting the daily usage of cholesterol lowering drugs, called statins, according to a study released in the New England Journal of Medicine. In a trial spanning six continents, 21 countries and 12,705 ethnically diverse participants, the researchers randomly assigned placebos and low dosages of statins or antihypertensives, such as rosuvastatin and candesartan plus hydrochlorothiazide.

    Comment?

  14. HOPE 3 Trial Supports Broader Use of Statins in Intermediate-Risk PopulationsRead the original story

    Apr 4, 2016 | P&T Community

    Statins may significantly reduce adverse cardiovascular events in people with average cholesterol and blood pressure levels who are considered to be at intermediate risk for cardiovascular disease, while the use of BP-lowering medications may be beneficial only in hypertensive patients, according to three reports from the HOPE-3 trial. The new findings were presented on April 2 at the American College of Cardiology's 65th Annual Scientific Session & Expo, held in Chicago, and were published simultaneously in the New England Journal of Medicine.

    Comment?

  15. Study supports broader use of statins in intermediate-risk populationsRead the original story w/Photo

    Apr 4, 2016 | Medical News Today

    Lowering cholesterol with statins significantly reduced adverse cardiovascular events in people with average cholesterol and blood pressure levels who were considered to be at intermediate risk for heart disease , while the use of blood pressure-lowering medications was beneficial only in those with higher blood pressure levels, according to three separate reports from the large HOPE-3 trial presented at the American College of Cardiology's 65th Annual Scientific Session. Previous studies have focused on the impacts of cholesterol and blood pressure-lowering drugs for people with established cardiovascular or renal disease, diabetes , other high risk conditions or in those with markedly elevated cholesterol or blood pressure levels.

    Comment?

  16. Statins Benefit Lower Risk Patients: Global StudyRead the original story w/Photo

    Apr 4, 2016 | News Max

    The first major research of its kind shows that cholesterol-lowering statins can prevent heart attacks and strokes in a globally diverse group of older people who don't have heart disease. The results bolster recommendations in recent guidelines on who should consider taking the drugs.

    Comment?

  17. Research backs far wider use of statinsRead the original story w/Photo

    Apr 3, 2016 | CNN

    The participants in the study spanned six continents and were in a variety of ethnic groups; 46% of the participants were women In an effort to reduce cardiovascular disease, which causes 18 million deaths globally per year and affects more than 1 billion adults worldwide, researchers are suggesting the daily usage of cholesterol lowering drugs, called statins, according to a study released in the New England Journal of Medicine. In a trial spanning six continents, 21 countries and 12,705 ethnically diverse participants, the researchers randomly assigned placebos and low dosages of statins or antihypertensives, such as rosuvastatin and candesartan plus hydrochlorothiazide.

    Comment?

  18. Major global study shows statins can prevent heart attacks and strokes in lower risk patientsRead the original story w/Photo

    Apr 3, 2016 | South China Morning Post

    The results could prod far more doctors to add a statin to blood pressure therapy for people who have no prior history of heart problems The first major research of its kind suggested that healthy people may reduce their risk of developing heart problems before they start by taking cholesterol-lowering drugs, known as statins. The findings came from three trials, which included more than 12,000 people in 21 countries, and were released at the American College of Cardiology conference in Chicago.

    Comment?

  19. Statins found to be heart disease aidRead the original story w/Photo

    Apr 2, 2016 | Pittsburgh Post-Gazette

    The first major research of its kind shows that cholesterol-lowering statins can prevent heart attacks and strokes in a globally diverse group of older people who don't have heart disease. The aim was to prevent heart problems using a statin alone, blood pressure drugs or a combination of the two.

    Comment?

  20. Global research sees statin benefits in lower risk patientsRead the original story w/Photo

    Apr 2, 2016 | HeraldNet

    The first major research of its kind shows that cholesterol-lowering statins can prevent heart attacks and strokes in a globally diverse group of older people who don't have heart disease. The aim was to prevent heart problems using a statin alone, blood pressure drugs or a combination of the two.

    Comment?